ロード中...
B2M overexpression correlates with malignancy and immune signatures in human gliomas
Because of the limited treatment strategy of gliomas, the key of diagnosis and treatment is finding new molecular biomarkers. Here, we explored the potential of β2-microglobulin (B2M) to serve as a hopeful candidate for immunotherapy or diagnostic biomarker in gliomas. The genomic profiles, clinical...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930032/ https://ncbi.nlm.nih.gov/pubmed/33658560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84465-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|